|Articles|November 30, 2012

Supplements and Featured Publications

  • A Novel Gastroretentive Formulation of Gabapentin for the Treatment of Postherpetic Neuralgia

A Novel Gastroretentive Formulation of Gabapentin for the Treatment of Postherpetic Neuralgia

Despite its efficacy for the treatment of postherpetic neuralgia, the potential benefits from treatment with gabapentin may be somewhat limited by its intrinsic properties. Gabapentin’s absorption characteristics—its active and saturable uptake within a narrow absorption window in the upper small intestine—pointed to the utility of a gastroretentive (GR) dosage form to improve the absorption of gabapentin at clinically relevant doses.

Information about the GR formulation of gabapentin is available in a recently released newsletter. To view the full newsletter, please click here or the image below.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo